Vaccines against Botulism
Botulinum neurotoxins (BoNT) cause the flaccid paralysis of botulism by inhibiting the release of acetylcholine from motor neurons. There are seven serotypes of BoNT (A-G), with limited therapies, and no FDA approved vaccine for botulism. An investigational formalin-inactivated penta-serotype-BoNT/A...
Main Authors: | Grace Sundeen, Joseph T. Barbieri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-09-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/9/9/268 |
Similar Items
-
Evaluation of Aluminium Hydroxide Nanoparticles as an Efficient Adjuvant to Potentiate the Immune Response against <i>Clostridium botulinum</i> Serotypes C and D Toxoid Vaccines
by: Ziphezinhle Mbhele, et al.
Published: (2023-09-01) -
Recent Developments in Vaccine Design: From Live Vaccines to Recombinant Toxin Vaccines
by: Sonal Gupta, et al.
Published: (2023-09-01) -
Four Cases of Food-Borne Botulism in a Family
by: Fariba Keramat
Published: (2002-12-01) -
Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997–2019
by: Marina Peñuelas, et al.
Published: (2022-12-01) -
Botulism: A Frequently Forgotten Old Malady
by: Teguh Thajeb, et al.
Published: (2007-09-01)